Ironwood Pharmaceuticals, Inc. Class A Common Stock (I76)
XDUS
Closed
Oct 8, 2026
Day's Range
3.2252 wk Range
1.19Overview - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
382.34M
P/E (Trailing)
‪21.33‬
PEG Ratio
‪0.20‬
Price / Book
‪-3.25‬
EV / EBITDA
‪3.06‬
Profitability
Operating Margin
‪34.70%‬
Return on Assets
‪6.05%‬
Return on Equity
‪-9.17%‬
Ownership
Shares Outstanding
165.23M
Price stats
50-Day Avg
‪3.54‬
200-Day Avg
‪3.39‬
Peers - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- I76XDUSIronwood Pharmaceuticals, Inc. Class A Common Stock+59.06%52-week change21.33P/E (Trailing)—Profit Margin
- PA8XDUSPaion AG+74.75%52-week change-0.76P/E (Trailing)‪94.10%‬Profit Margin
- 6CWXDUSCharlottes Web Holdings Inc.+69.26%52-week change-1.28P/E (Trailing)‪43.48%‬Profit Margin
- 20MPXDUSThe More Life Company Corp.+67.44%52-week change-3.44P/E (Trailing)—Profit Margin
- NGQ1XDUSMedicure Inc.+65.12%52-week change-2.38P/E (Trailing)‪40.71%‬Profit Margin
- HLSXDUSAIC Mines Limited+59.24%52-week change—P/E (Trailing)—Profit Margin
- E7PXDUSIndivior Pharmaceuticals, Inc.+54.46%52-week change18.69P/E (Trailing)‪80.14%‬Profit Margin
Profile Summary - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
About
Ironwood Pharmaceuticals, Inc. Class A Common Stock represents ownership in Ironwood Pharmaceuticals, Inc., a biotechnology company focused on developing and commercializing therapies for gastrointestinal disorders and rare diseases. Its current business centers on human therapeutics, with an emphasis on medicines for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
